Navigation Links
Amylin Pharmaceuticals Highlights 2009 Value Creation Opportunities
Date:1/12/2009

Product and Operational Targets Presented At JPMorgan Healthcare Conference

SAN FRANCISCO, Jan. 12 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced product and operational targets for 2009 that provide the opportunity to transform diabetes and obesity treatment and position the Company to be cash flow positive by the end of 2010. The news was presented by Daniel M. Bradbury, president and chief executive officer, at the JPMorgan Healthcare Conference in San Francisco, CA.

"The epidemics of diabetes and obesity, which synergistically contribute to cardiovascular disease, are the major health crises of our lifetime," said Bradbury. "The significant unmet need in the diabetes and obesity markets provides an opportunity for Amylin's first-in-class therapies to create tremendous benefit. We look to 2009 to further improve health outcomes for patients, physicians and payors, and to increase shareholder value."

2009 CORPORATE TARGETS

During his remarks, Bradbury highlighted the key 2009 value creation opportunities for Amylin. These targets include the following:

  • Gain approval for an expanded indication of BYETTA as a monotherapy, finalize label updates and return the product to growth
  • Leverage knowledge gained from BYETTA to submit the New Drug Application (NDA) for exenatide once weekly and execute the DURATION head-to-head clinical program designed to show comparative superiority
  • Continue growing SYMLIN revenue
  • Complete obesity clinical trials with amylin/leptin analogs and finalize obesity development and funding strategy
  • Improve operating results and make significant progress toward achieving positive operating cash flow by the end of 2010
'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... , February 9 ,, ... Potential of Microplasmin to Improve the Treatment,of a ... ThromboGenics NV (Euronext Brussels: ... development of innovative treatments for eye,disease, vascular disease ... II trial results, evaluating the product,s efficacy and,safety ...
(Date:2/8/2010)... Kennedy Space Center this morning, carrying on board the eighth ... use microgravity to develop the foundation of new medicines. ... ... Space Shuttle Endeavor lifted off from NASA’s Kennedy Space Center ... Astrogenetix, a commercial biotech company created to use microgravity to ...
(Date:2/8/2010)... Feb. 8 Corgenix Medical Corporation ... of diagnostic test kits, and Tulane University , ... to combat viral hemorrhagic fever (VHF), an effort that ... revenue for Corgenix over the life of the contract. ... awarded a five-year contract totaling $15,224,927 to ...
(Date:2/8/2010)... strategic communications agency, announced today that it has been selected ... services in Asia Pacific, to develop and execute its corporate ... ... Salem, MA (Vocus) February 8, 2010 -- LaVoie ... that it has been selected by Invida Group , ...
Breaking Biology Technology:ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 3ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 4Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor 2Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7Invida Selects LaVoie Group as Public Relations Agency of Record 2Invida Selects LaVoie Group as Public Relations Agency of Record 3
... There are millions of very expensive, well-designed websites all ... to offer with great graphic illustrations, supportive explanations about ... ,But in a very large majority of cases, what ... the people behind the site: the owners, the management ...
... computing performance were developed at the computer ... at the University of Wisconsin-Madison. , ,Innovations that ... and cluster computing were some of the technologies ... other faculty last Wednesday at Accelerate Madisons monthly ...
... Medical College of Wisconsin announced on Tuesday that it plans ... automate all phases of its research concerning human subjects. Expected ... part of a long-range plan to fully enhance the institution's ... the growing volume of research, as the Medical College ...
Other Biology Technology:Whats Hush-Hush Marketing? 2Whats Hush-Hush Marketing? 3UW computer scientists tout achievements and explain industry shortcomings 2UW computer scientists tout achievements and explain industry shortcomings 3Medical College of Wisconsin to automate its processes for human subject testing 2
(Date:2/8/2010)... The recent trend towards earlier UK springs and ... published today (9 February 2010) in the scientific ... The collaborative study, involving scientists from 12 UK ... most comprehensive and rigorous assessment so far of ... biological events across marine, freshwater and terrestrial environments ...
(Date:2/8/2010)... 9, 2010 Cellular imaging offers a wealth of ... this technique to study biological systems is a daunting ... Genome Research ( www.genome.org ), researchers have developed ... to identify genetic interactions within biological networks, offering a ... , For years, scientists have been peering through a ...
(Date:2/8/2010)... [Brown University] Around 30 to 40 million years ... An assemblage capitalized on falling levels of atmospheric carbon ... dwindling CO2 supply that, like a fuel-injection system in ... into energy. , The rise of C4 grasses is ... now make up to 20 percent of our planet,s ...
Breaking Biology News(10 mins):Will earlier springs throw nature out of step? 2Method of the future uses single-cell imaging to identify gene interactions 2Brown biologist solves mystery of tropical grasses' origin 2Brown biologist solves mystery of tropical grasses' origin 3Designing drugs and their antidotes together improves patient care 58829 1Designing drugs and their antidotes together improves patient care 58829 2Designing drugs and their antidotes together improves patient care 58829 3Global death toll 3A 1 million premature babies every year 58827 1Global death toll 3A 1 million premature babies every year 58827 2Global death toll 3A 1 million premature babies every year 58827 3Global death toll 3A 1 million premature babies every year 58827 4Study finds 231 new genes associated with head and neck cancer 10252 1Study finds 231 new genes associated with head and neck cancer 10252 2
... discovered a legless lizard and a tiny woodpecker along ... one of the worlds 34 biodiversity conservation hotspots. , ... the size of Europe, but is now being converted ... the neighboring Amazon rainforest, resulting in the loss of ...
... The National Academy of Sciences today elected Dr. David ... and a Howard Hughes Medical Institute investigator, to membership, ... scientist. , Three other Texans, all from UT Austin, ... associates who were elected today to the NAS. They ...
... member of the Basic Sciences Division at Fred Hutchinson ... the American Academy of Arts & Sciences, or AAAS, ... societies and independent policy-research centers., She is among 190 new ... AAAS 2008 class of fellows. Drawn from the sciences, ...
Other Biology News:New species discovered in Brazil 2UT Southwestern's Mangelsdorf elected to National Academy of Sciences 2UT Southwestern's Mangelsdorf elected to National Academy of Sciences 3Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows 2Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows 3
Vitronectin Immunogen: Purified, full length, native human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... The Staccato Application Series are ... systems designed to provide fast and ... Utilizing proven and robust "automation-friendly" building ... solutions that cost less than conventional ...
...
... 2-Methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidine-4-one White solid. PROTECT ... brain-permeable and water soluble pyrimidinone compound that ... -competitive inhibitor of PARP (IC 50 ... rhPARP1 and rmPARP2, respectively) with little activity ...
Biology Products: